
FDA approves sublingual, nonopioid daily treatment for fibromyalgia
The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine hydrochloride) sublingual tablets for the treatment of fibromyalgia in adults.This article was originally published on MedicalXpress.com